Literature DB >> 7411162

Double discharges of distal origin: influence on the firing rhythm.

G Roth.   

Abstract

Double discharges, or doublets, following the direct M response after peripheral nerve stimulation had a distal origin on the axon and were accompanied bay a back-response. This antidromic wave was demonstrated by collision technique or by its occasional recurrent F wave. Double discharges (DD) with a long interval between the two components had their origin in one subunit and were transmitted to another by motor axon reflex. Increse of the post-doublet interval (PDI) duration during EMG was best explained by invasion of the alpha cell by the back-response and the resetting of a new cycle. This invasion was sometimes followed by a recurrent F wave: a shorter PDI resulted. Normal PDI were probably due to blocking of the back-response at the myelinated-non-myelinated junction, without alpha cell invasion: weak or absent Renshaw inhibitory effect on the alpha cell concerned seemed to play a role.

Mesh:

Year:  1980        PMID: 7411162     DOI: 10.1016/0022-510x(80)90023-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Repetitive doublets in human flexor carpi radialis muscle.

Authors:  P Bawa; B Calancie
Journal:  J Physiol       Date:  1983-06       Impact factor: 5.182

2.  Repetitive compound muscle action potentials in electrophysiological diagnosis of congenital myasthenic syndromes: a case report and review of literature.

Authors:  R Shiva Kumar; Abraham Kuruvilla
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

3.  Motor unit firing pattern: evidence for motoneuronal or axonal discharge origin?

Authors:  Lydia P Kudina; Regina E Andreeva
Journal:  Neurol Sci       Date:  2015-08-04       Impact factor: 3.307

4.  Triplet firing origin in human motor units: emerging hypotheses.

Authors:  Lydia P Kudina; Regina E Andreeva
Journal:  Exp Brain Res       Date:  2015-12-12       Impact factor: 1.972

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.